When will the first generic GLP-1 launch in the US?

Resolution

Rule

This market resolves to the quarter in which the first FDA-approved generic semaglutide or tirzepatide becomes available for purchase in the United States. Source: FDA approval announcements, manufacturer press releases, or pharmacy availability data. If no generic GLP-1 launches by end of 2026, this market resolves to "No Launch in Window."

Source: https://www.fda.gov/

Resolves by May 23, 2027.